STAT3 and ovarian carcinoma: STAT3 activity is induced by hypoxia and not only regulates proliferation under hypoxic conditions, but also confers both cisplatin and paclitaxel resistance, in part by priming ovarian cancer stem cells to survive in adverse conditions [49,91,92].